 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Genes and HIV Progression
6 November 2001 | Volume 135 Issue 9 | Page S52
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Effects of CCR5-
32, CCR2-64I, and SDF-1 3'A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data." It is in the 6 November 2001 issue of Annals of Internal Medicine (volume 135, pages 782-795). The authors are JPA Ioannidis, PS Rosenberg, JJ Goedert, LJ Ashton, TL Benfield, SP Buchbinder, RA Coutinho, J Eugen-Olsen, T Gallart, TL Katzenstein, LG Kostrikis, H Kuipers, LG Louie, SA Mallal, JB Margolick, OP Martinez, L Meyer, NL Michael, E Operskalski, G Pantaleo, GP Rizzardi, H Schuitemaker, HW Sheppard, GJ Stewart, ID Theodorou, H Ullum, E Vicenzi, D Vlahov, D Wilkinson, C Workman, J-F Zagury, and TR O'Brien, for the International Meta-Analysis of HIV Host Genetics.
What is the problem and what is known about it so far?
There are more than 30,000 genes in a human body cell. Each gene in a pair is located in the same place on a pair of similar chromosomes. Genes have alternate forms that are known as alleles. A gene may have a few or several hundred different alleles. Different alleles account for inherited differences between individuals, such as varying eye color. Alleles may also play a part in the cause and progression of diseases. For example, individuals differ in the likelihood of developing AIDS after becoming infected with HIV-1. Differences in alleles probably cause these differences between individuals. However, whether specific alleles promote progression to AIDS has not been clear.
Why did the researchers do this particular study?
To see whether certain genetic alleles are associated with progression of HIV-1 disease.
Who was studied?
4504 people with HIV-1 infection who were of African or European descent.
How was the study done?
The researchers analyzed information from previous studies that had tested for associations between genetic alleles and the course of HIV-1 infection. The studies had been conducted by 19 groups of researchers in the United States, Europe, and Australia. In each study, the authors periodically checked a group of people with HIV-1 infection to see who developed AIDS or died. All study participants had had special genetic testing to determine whether or not they carried particular alleles (CCR5- 32, CCR2-64I, SDF-1 3'A) that have been suspected to affect progression of HIV infection. The authors combined the results from all of the studies in a special way (individual-patient–based meta-analysis) to see which alleles were associated with AIDS or death.
What did the researchers find?
The CCR5- 32 and CCR2-64I alleles were associated with a decreased risk for progression to AIDS and a decreased risk for death. These alleles did not protect against death once AIDS had developed. In contrast to some prior reports, having the SDF-1 3'A allele was not associated with progression to AIDS or death.
What were the limitations of the study?
Some patients had had HIV-1 infection for varying periods of time when they entered the studies. Patients who had rapidly progressed from HIV-1 infection to AIDS or death may not have been included in the study. This might mean that alleles responsible for rapid progression or death were not identified. Moreover, only patients of African or European descent were included in the meta-analysis.
What are the implications of the study?
Particular alleles (CCR5- 32 and CCR2-64I) protect against disease progression in patients with HIV-1 infection. Drugs that imitate the effect of these alleles might delay progression of HIV infection. Whether and how such alleles influence response to antiviral therapies are currently being studied.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  D. D. G. Despriet, A. A. B. Bergen, J. E. Merriam, J. Zernant, G. R. Barile, R. T. Smith, I. A. Barbazetto, S. van Soest, A. Bakker, P. T. V. M. de Jong, et al. Comprehensive Analysis of the Candidate Genes CCL2, CCR2, and TLR4 in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 364 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Friedrich, L. E. Valentine, L. J. Yant, E. G. Rakasz, S. M. Piaskowski, J. R. Furlott, K. L. Weisgrau, B. Burwitz, G. E. May, E. J. Leon, et al. Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication J. Virol., April 1, 2007; 81(7): 3465 - 3476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pilotti, L. Elviri, E. Vicenzi, U. Bertazzoni, M. C. Re, S. Allibardi, G. Poli, and C. Casoli Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication Blood, March 1, 2007; 109(5): 1850 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xiang, J. H. McLinden, Q. Chang, T. M. Kaufman, and J. T. Stapleton An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells PNAS, October 17, 2006; 103(42): 15570 - 15575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lederman, A. Penn-Nicholson, M. Cho, and D. Mosier Biology of CCR5 and its role in HIV infection and treatment. JAMA, August 16, 2006; 296(7): 815 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Duell, D. P. Casella, R. D. Burk, K. T. Kelsey, and E. A. Holly Inflammation, Genetic Polymorphisms in Proinflammatory Genes TNF-A, RANTES, and CCR5, and Risk of Pancreatic Adenocarcinoma. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 726 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hladik, H. Liu, E. Speelmon, D. Livingston-Rosanoff, S. Wilson, P. Sakchalathorn, Y. Hwangbo, B. Greene, T. Zhu, and M. J. McElrath Combined Effect of CCR5-{Delta}32 Heterozygosity and the CCR5 Promoter Polymorphism -2459 A/G on CCR5 Expression and Resistance to Human Immunodeficiency Virus Type 1 Transmission J. Virol., September 15, 2005; 79(18): 11677 - 11684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Bracken Genomic Epidemiology of Complex Disease: The Need for an Electronic Evidence-based Approach to Research Synthesis Am. J. Epidemiol., August 15, 2005; 162(4): 297 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Ioannidis, S. H. Ralston, S. T. Bennett, M. L. Brandi, D. Grinberg, F. B. Karassa, B. Langdahl, J. B. J. van Meurs, L. Mosekilde, S. Scollen, et al. Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes JAMA, November 3, 2004; 292(17): 2105 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Williams, D. Klinzman, T. E. Yamashita, J. Xiang, P. M. Polgreen, C. Rinaldo, C. Liu, J. Phair, J. B. Margolick, D. Zdunek, et al. Persistent GB Virus C Infection and Survival in HIV-Infected Men N. Engl. J. Med., March 4, 2004; 350(10): 981 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Silverberg, M. W. Smith, J. S. Chmiel, R. Detels, J. B. Margolick, C. R. Rinaldo, S. J. O'Brien, and A. Munoz Fraction of Cases of Acquired Immunodeficiency Syndrome Prevented by the Interactions of Identified Restriction Gene Variants Am. J. Epidemiol., February 1, 2004; 159(3): 232 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Llano, J. Barretina, A. Gutierrez, B. Clotet, and J. A. Este Interleukin-7-Dependent Production of RANTES That Correlates with Human Immunodeficiency Virus Disease Progression J. Virol., April 1, 2003; 77(7): 4389 - 4395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vicenzi, P. Panina-Bodignon, G. Vallanti, P. Di Lucia, and G. Poli Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4+ T cells J. Leukoc. Biol., November 1, 2002; 72(5): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Kostrikis, G. Touloumi, R. Karanicolas, N. Pantazis, C. Anastassopoulou, A. Karafoulidou, J. J. Goedert, and A. Hatzakis Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load J. Virol., September 11, 2002; 76(20): 10099 - 10108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Little, L. Bradley, M. S. Bray, M. Clyne, J. Dorman, D. L. Ellsworth, J. Hanson, M. Khoury, J. Lau, T. R. O'Brien, et al. Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations Am. J. Epidemiol., August 15, 2002; 156(4): 300 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Ioannidis, P. S. Rosenberg, J. J. Goedert, and T. R. O'Brien Commentary: Meta-analysis of Individual Participants' Data in Genetic Epidemiology Am. J. Epidemiol., August 1, 2002; 156(3): 204 - 210. [Full Text] [PDF]
|
|
|
|
|
|
J. Tang, B. Shelton, N. J. Makhatadze, Y. Zhang, M. Schaen, L. G. Louie, J. J. Goedert, E. C. Seaberg, J. B. Margolick, J. Mellors, et al. Distribution of Chemokine Receptor CCR2 and CCR5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (HIV-1) Seroconversion, Early HIV-1 RNA Concentration in Plasma, and Later Disease Progression J. Virol., January 15, 2002; 76(2): 662 - 672. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
